Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Advanced Therapy Based on Gene Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Viral
1.2.3 Non-viral
1.3 Market by Application
1.3.1 Global Advanced Therapy Based on Gene Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Advanced Therapy Based on Gene Market Perspective (2018-2033)
2.2 Advanced Therapy Based on Gene Growth Trends by Region
2.2.1 Global Advanced Therapy Based on Gene Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Advanced Therapy Based on Gene Historic Market Size by Region (2018-2023)
2.2.3 Advanced Therapy Based on Gene Forecasted Market Size by Region (2024-2033)
2.3 Advanced Therapy Based on Gene Market Dynamics
2.3.1 Advanced Therapy Based on Gene Industry Trends
2.3.2 Advanced Therapy Based on Gene Market Drivers
2.3.3 Advanced Therapy Based on Gene Market Challenges
2.3.4 Advanced Therapy Based on Gene Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Advanced Therapy Based on Gene Players by Revenue
3.1.1 Global Top Advanced Therapy Based on Gene Players by Revenue (2018-2023)
3.1.2 Global Advanced Therapy Based on Gene Revenue Market Share by Players (2018-2023)
3.2 Global Advanced Therapy Based on Gene Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Advanced Therapy Based on Gene Revenue
3.4 Global Advanced Therapy Based on Gene Market Concentration Ratio
3.4.1 Global Advanced Therapy Based on Gene Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Advanced Therapy Based on Gene Revenue in 2022
3.5 Advanced Therapy Based on Gene Key Players Head office and Area Served
3.6 Key Players Advanced Therapy Based on Gene Product Solution and Service
3.7 Date of Enter into Advanced Therapy Based on Gene Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Advanced Therapy Based on Gene Breakdown Data by Type
4.1 Global Advanced Therapy Based on Gene Historic Market Size by Type (2018-2023)
4.2 Global Advanced Therapy Based on Gene Forecasted Market Size by Type (2024-2033)
5 Advanced Therapy Based on Gene Breakdown Data by Application
5.1 Global Advanced Therapy Based on Gene Historic Market Size by Application (2018-2023)
5.2 Global Advanced Therapy Based on Gene Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Advanced Therapy Based on Gene Market Size (2018-2033)
6.2 North America Advanced Therapy Based on Gene Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Advanced Therapy Based on Gene Market Size by Country (2018-2023)
6.4 North America Advanced Therapy Based on Gene Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Advanced Therapy Based on Gene Market Size (2018-2033)
7.2 Europe Advanced Therapy Based on Gene Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Advanced Therapy Based on Gene Market Size by Country (2018-2023)
7.4 Europe Advanced Therapy Based on Gene Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Advanced Therapy Based on Gene Market Size (2018-2033)
8.2 Asia-Pacific Advanced Therapy Based on Gene Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Advanced Therapy Based on Gene Market Size by Region (2018-2023)
8.4 Asia-Pacific Advanced Therapy Based on Gene Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Advanced Therapy Based on Gene Market Size (2018-2033)
9.2 Latin America Advanced Therapy Based on Gene Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Advanced Therapy Based on Gene Market Size by Country (2018-2023)
9.4 Latin America Advanced Therapy Based on Gene Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Advanced Therapy Based on Gene Market Size (2018-2033)
10.2 Middle East & Africa Advanced Therapy Based on Gene Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Advanced Therapy Based on Gene Market Size by Country (2018-2023)
10.4 Middle East & Africa Advanced Therapy Based on Gene Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Detail
11.1.2 Biogen Business Overview
11.1.3 Biogen Advanced Therapy Based on Gene Introduction
11.1.4 Biogen Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Advanced Therapy Based on Gene Introduction
11.2.4 Novartis Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Advanced Therapy Based on Gene Introduction
11.3.4 Gilead Sciences Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Detail
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Advanced Therapy Based on Gene Introduction
11.4.4 Sarepta Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Detail
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Advanced Therapy Based on Gene Introduction
11.6.4 Amgen Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Detail
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Advanced Therapy Based on Gene Introduction
11.7.4 Spark Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.7.5 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Detail
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Advanced Therapy Based on Gene Introduction
11.8.4 Akcea Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.8.5 Akcea Therapeutics Recent Development
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Detail
11.9.2 Sunway Biotech Business Overview
11.9.3 Sunway Biotech Advanced Therapy Based on Gene Introduction
11.9.4 Sunway Biotech Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.9.5 Sunway Biotech Recent Development
11.10 SIBIONO
11.10.1 SIBIONO Company Detail
11.10.2 SIBIONO Business Overview
11.10.3 SIBIONO Advanced Therapy Based on Gene Introduction
11.10.4 SIBIONO Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.10.5 SIBIONO Recent Development
11.11 AnGes
11.11.1 AnGes Company Detail
11.11.2 AnGes Business Overview
11.11.3 AnGes Advanced Therapy Based on Gene Introduction
11.11.4 AnGes Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.11.5 AnGes Recent Development
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Detail
11.12.2 Orchard Therapeutics Business Overview
11.12.3 Orchard Therapeutics Advanced Therapy Based on Gene Introduction
11.12.4 Orchard Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.12.5 Orchard Therapeutics Recent Development
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Detail
11.13.2 Human Stem Cells Institute Business Overview
11.13.3 Human Stem Cells Institute Advanced Therapy Based on Gene Introduction
11.13.4 Human Stem Cells Institute Revenue in Advanced Therapy Based on Gene Business (2018-2023)
11.13.5 Human Stem Cells Institute Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Advanced Therapy Based on Gene Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Viral
Table 3. Key Players of Non-viral
Table 4. Global Advanced Therapy Based on Gene Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Advanced Therapy Based on Gene Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Advanced Therapy Based on Gene Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Advanced Therapy Based on Gene Market Share by Region (2018-2023)
Table 8. Global Advanced Therapy Based on Gene Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Advanced Therapy Based on Gene Market Share by Region (2024-2033)
Table 10. Advanced Therapy Based on Gene Market Trends
Table 11. Advanced Therapy Based on Gene Market Drivers
Table 12. Advanced Therapy Based on Gene Market Challenges
Table 13. Advanced Therapy Based on Gene Market Restraints
Table 14. Global Advanced Therapy Based on Gene Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Advanced Therapy Based on Gene Market Share by Players (2018-2023)
Table 16. Global Top Advanced Therapy Based on Gene Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Based on Gene as of 2022)
Table 17. Ranking of Global Top Advanced Therapy Based on Gene Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Advanced Therapy Based on Gene Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Advanced Therapy Based on Gene Product Solution and Service
Table 21. Date of Enter into Advanced Therapy Based on Gene Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Advanced Therapy Based on Gene Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Advanced Therapy Based on Gene Revenue Market Share by Type (2018-2023)
Table 25. Global Advanced Therapy Based on Gene Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Advanced Therapy Based on Gene Revenue Market Share by Type (2024-2033)
Table 27. Global Advanced Therapy Based on Gene Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Advanced Therapy Based on Gene Revenue Market Share by Application (2018-2023)
Table 29. Global Advanced Therapy Based on Gene Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Advanced Therapy Based on Gene Revenue Market Share by Application (2024-2033)
Table 31. North America Advanced Therapy Based on Gene Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Advanced Therapy Based on Gene Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Advanced Therapy Based on Gene Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Advanced Therapy Based on Gene Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Advanced Therapy Based on Gene Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Advanced Therapy Based on Gene Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Advanced Therapy Based on Gene Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Advanced Therapy Based on Gene Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Advanced Therapy Based on Gene Market Size by Country (2024-2033) & (US$ Million)
Table 46. Biogen Company Detail
Table 47. Biogen Business Overview
Table 48. Biogen Advanced Therapy Based on Gene Product
Table 49. Biogen Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Advanced Therapy Based on Gene Product
Table 54. Novartis Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Detail
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Advanced Therapy Based on Gene Product
Table 59. Gilead Sciences Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Detail
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Advanced Therapy Based on Gene Product
Table 64. Sarepta Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Detail
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product
Table 69. Alnylam Pharmaceuticals Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Advanced Therapy Based on Gene Product
Table 74. Amgen Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Spark Therapeutics Company Detail
Table 77. Spark Therapeutics Business Overview
Table 78. Spark Therapeutics Advanced Therapy Based on Gene Product
Table 79. Spark Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 80. Spark Therapeutics Recent Development
Table 81. Akcea Therapeutics Company Detail
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Advanced Therapy Based on Gene Product
Table 84. Akcea Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. Sunway Biotech Company Detail
Table 87. Sunway Biotech Business Overview
Table 88. Sunway Biotech Advanced Therapy Based on Gene Product
Table 89. Sunway Biotech Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 90. Sunway Biotech Recent Development
Table 91. SIBIONO Company Detail
Table 92. SIBIONO Business Overview
Table 93. SIBIONO Advanced Therapy Based on Gene Product
Table 94. SIBIONO Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 95. SIBIONO Recent Development
Table 96. AnGes Company Detail
Table 97. AnGes Business Overview
Table 98. AnGes Advanced Therapy Based on Gene Product
Table 99. AnGes Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 100. AnGes Recent Development
Table 101. Orchard Therapeutics Company Detail
Table 102. Orchard Therapeutics Business Overview
Table 103. Orchard Therapeutics Advanced Therapy Based on Gene Product
Table 104. Orchard Therapeutics Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 105. Orchard Therapeutics Recent Development
Table 106. Human Stem Cells Institute Company Detail
Table 107. Human Stem Cells Institute Business Overview
Table 108. Human Stem Cells Institute Advanced Therapy Based on Gene Product
Table 109. Human Stem Cells Institute Revenue in Advanced Therapy Based on Gene Business (2018-2023) & (US$ Million)
Table 110. Human Stem Cells Institute Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Advanced Therapy Based on Gene Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Advanced Therapy Based on Gene Market Share by Type: 2022 VS 2033
Figure 3. Viral Features
Figure 4. Non-viral Features
Figure 5. Global Advanced Therapy Based on Gene Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Advanced Therapy Based on Gene Market Share by Application: 2022 VS 2033
Figure 7. Neurological Diseases Case Studies
Figure 8. Cancer Case Studies
Figure 9. Other Case Studies
Figure 10. Advanced Therapy Based on Gene Report Years Considered
Figure 11. Global Advanced Therapy Based on Gene Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Advanced Therapy Based on Gene Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Advanced Therapy Based on Gene Market Share by Region: 2022 VS 2033
Figure 14. Global Advanced Therapy Based on Gene Market Share by Players in 2022
Figure 15. Global Top Advanced Therapy Based on Gene Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Based on Gene as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Advanced Therapy Based on Gene Revenue in 2022
Figure 17. North America Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Advanced Therapy Based on Gene Market Share by Country (2018-2033)
Figure 19. United States Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Advanced Therapy Based on Gene Market Share by Country (2018-2033)
Figure 23. Germany Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Advanced Therapy Based on Gene Market Share by Region (2018-2033)
Figure 31. China Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Advanced Therapy Based on Gene Market Share by Country (2018-2033)
Figure 39. Mexico Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Advanced Therapy Based on Gene Market Share by Country (2018-2033)
Figure 43. Turkey Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Advanced Therapy Based on Gene Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Biogen Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 46. Novartis Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 47. Gilead Sciences Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 48. Sarepta Therapeutics Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 51. Spark Therapeutics Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 52. Akcea Therapeutics Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 53. Sunway Biotech Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 54. SIBIONO Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 55. AnGes Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 56. Orchard Therapeutics Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 57. Human Stem Cells Institute Revenue Growth Rate in Advanced Therapy Based on Gene Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed